期刊文献+

瑞舒伐他汀联用通心络对颈动脉粥样斑块影响的研究 被引量:10

下载PDF
导出
摘要 目的观察瑞舒伐他汀联用通心络对颈动脉粥样斑块的影响。方法将106例颈动脉粥样硬化患者随机分为2组,对照组56例给予瑞舒伐他汀钙片10 mg/d口服,治疗组在对照组基础上加服通心络胶囊,3粒/次,3次/d,2组均治疗6个月。治疗前后分别应用彩超检测颈动脉斑块大小、斑块厚度、斑块积分、血管内中膜厚度(IMT),并比较2组调脂及缩小粥样斑块的疗效。结果 2组治疗后总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、三酰甘油(TG)水平均较治疗前明显降低(P均<0.01),高密度脂蛋白胆固醇(HDL-C)水平均较治疗前升高(P均<0.05),治疗组HDL-C比对照组升高更明显(P<0.05);疗程结束后,治疗组在减小斑块大小、斑块厚度、斑块积分、IMT等方面效果均优于对照组(P均<0.01)。结论瑞舒伐他汀和通心络胶囊联合应用在调脂、缩小粥样斑块等方面效果均优于单用瑞舒伐他汀。
出处 《现代中西医结合杂志》 CAS 2013年第16期1738-1739,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
基金 北海巿科学研究与技术开发项目(北科合20110901)
  • 相关文献

参考文献10

  • 1邹海枫,陈国梁,张燕.彩色多普勒超声在颈动脉斑块诊断及治疗中的应用价值[J].中国医药科学,2011,1(18):94-95. 被引量:21
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 3Triposkiadis F,Sitafidis G,Kostoulas J,et al. Carotid plaque compo- sition in stable and unstable coronary artery disease[ J]. Am Heart J,2005,150(4) :782 -789.
  • 4Wenger NK, Lewis SJ,Welty FK,et al. Beneficial effects of aggres- sive low density lipoprotein cholesterol lowering in women with sta- ble coronary heart disease in the Treating to New Targets (TNT) study[J]. Heart,2008,94(4) :434 -439.
  • 5Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoproteincholesterol, ischaemic heart disease, and stroke : systematic review and meta-analysis [ J ]. BMJ, 2003,326 (28) :1423 - 1427.
  • 6Shimojima M, Kawashiri M, Nittal Y, et al. Rapid changes in p- laque composition and morphology after intensive lipid lowering ther- apy:study with serialcoronary CT angiography[ J]. Am J C ardiovasc Dis,2012,2(2) :84 - 88.
  • 7Andrew van Herick, C Andy Sehuetz, Peter Alperin,et al. The im- pact of initial statin treatment deeisions on cardiovascular outcomes in elinieal care settings:estimates using the Archimedes Model[ J]. ClinicoEconomics and Outcomes Research ,2012,4:337 - 347.
  • 8Sanjay K Gandhi,Marie M Jensen, Kathleen M Fox, et al. Cost-ef- fectiveness of rosuvastatinin comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular e- vents [ J]. Clinico Economics and Outcomes Research,2012,4 : 1 - 11.
  • 9Vassilis Fragoulakis, Georgia Kourlaba, Nikolaos Maniadakis. Eco- nomic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece [ J ]. Clinico Economics and Outcomes Research,2012,4:135 -143.
  • 10黄永康,陆青.通心络胶囊联合阿托伐他汀对高脂血症患者调脂及抑制动脉炎性反应的临床观察[J].临床合理用药杂志,2012,5(28):15-16. 被引量:13

二级参考文献161

共引文献5258

同被引文献148

引证文献10

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部